Onderneming Oragenics Inc Nyse
Aandelen
US6840232036
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Medical Products
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -71,37% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -71,37% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | 28/12 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 07-03-23 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 01-05-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 04-06-10 |
John Gandolfo
BRD | Director/Board Member | 63 | 04-10-23 |
Robert Koski
BRD | Director/Board Member | 65 | 30-06-09 |
Director/Board Member | 73 | 01-06-10 | |
Alan Dunton
BRD | Director/Board Member | 70 | 01-04-10 |
Bruce Cassidy
BRD | Director/Board Member | 74 | 04-10-23 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 01-05-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 7 488 692 | 0 | 0 | 76,77 % |
Aandeel B | 0 | 4 050 000 | 0 | 0 | |
Aandeel C | 1 | 4 480 693 | 3 439 769 ( 76,77 %) | 0 | |
Aandeel D | 0 | 5 417 000 | 0 | 0 |
Bedrijfsgegevens
Oragenics, Inc.
4902 Eisenhower boulevard Suite 125
33634-6310, Tampa
+813 286 7900
http://www.oragenics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,83% | 115 mld. | |
+10,80% | 105 mld. | |
-10,84% | 22,71 mld. | |
-1,69% | 21,83 mld. | |
-10,23% | 18,18 mld. | |
-41,92% | 16,52 mld. | |
-15,11% | 16,01 mld. | |
+6,62% | 14,14 mld. | |
+17,53% | 10,71 mld. |